MAPT and Alzheimer disease: As p75NTR is involved in the production of Aβ, neuronal death, neurite degeneration, tau hyper phosphorylation, cell cycle re-entry and cognition decline in AD [139], it is considered a novel therapeutic target and as a biomarker for AD [140] and also aids in increasing survival signalling in neurons [141].